Components of base excision repair participate in the processing of psoralen-induced DNA adducts.
2 of interstrand crosslinks. While exhibiting no enzymatic activity, purified NEIL1 protein bound stably to psoralen interstrand crosslink-containing synthetic oligonucleotide substrates in vitro. Our results indicate that NEIL1 recognizes specifically and distinctly interstrand crosslinks in DNA, and can obstruct the efficient removal of lethal crosslink adducts.
A wide spectrum of DNA damage is generated through spontaneous decomposition, reactions with endogenously produced chemical species, and direct or indirect interactions with various exogenous agents. Some of the most common forms of DNA damage include simple base alterations, abasic sites and single-strand breaks (1) . More complex lesions, which are more typically associated with environmental or clinical DNA-damaging agents, include helix-distorting (bulky) base adducts, double-strand breaks, and intra or interstrand crosslinks (2) . To prevent the genotoxic and lethal consequences of DNA damage, organisms have evolved a series of distinct, albeit interconnected, DNA repair mechanisms (3).
The base excision repair (BER) pathway is the predominant system for coping with spontaneous hydrolytic, oxidative and alkylative DNA modifications (4) . Such lesions include uracil, 8-oxoguanine, 3-methyladenine, apurinic/apyrimidinic (AP) sites, and a variety of DNA single-strand break ends. Classic BER involves substrate base removal by a DNA glycosylase, incision at the resulting abasic site by an AP endonuclease, gap-filling by a DNA polymerase and sealing of the remaining nick by a DNA ligase. Although BER has traditionally been thought to recognize lesions that have little impact on overall DNA structure, recent evidence has implicated a direct involvement of BER in the processing of interstrand crosslinks (5) . This damage involves the covalent linkage of the two complementary strands of DNA, thereby preventing strand separation that is required for events such as transcription and replication. Thus, interstrand crosslinks are highly toxic DNA modifications, which can promote genomic instability (6) .
Some of the early data that suggested a role for BER factors in the removal of DNA lesions formed by crosslinking agents includes the mild hypersensitivities reported for homozygous 3-methyladenine DNA glycosylase (MPG)-deficient mouse cells to bis-chloroethylnitrosourea and mitomycin C (7, 8) . Whether or not this increased sensitivity was the result of impaired removal of interstrand crosslinks or one of the many monoadducts formed by these compounds, however, was not determined. More recent data from the Samson laboratory indicate that MPG (also known as AAG) is important for resistance of mouse embryonic stem cells to psoraleninduced interstrand crosslinks, but not angelicininduced monoadducts, although the exact molecular process that engages MPG has not been elucidated (9) .
In a separate study, Saparbaev and colleagues found that the human DNA glycosylase, endonuclease VIII-like 1 (NEIL1), excises psoralen-induced monoadducts in duplex DNA, initiating a classic BER response involving the AP endonuclease APE1 (10) . Consistently, HeLa cells depleted for NEIL1 or APE1 were shown to be hypersensitive to 8-methoxypsoralen (+UVA) exposure, a treatment scheme that creates a significant percentage of monoadduct products (10, 11) . More recently, Saparbaev and colleagues found that NEIL1 can also excise an unhooked interstrand crosslink remnant within a synthetic three-stranded DNA structure, catalyzing a classic BER reaction in vitro (12) . These data imply multiple routes of entry for NEIL1 in the psoralen crosslink response.
Unlike the above work, which suggested a role for BER components in the repair of crosslink adducts, Patrick and colleagues found that cells deficient in BER display a cisplatin-resistant phenotype, which is accompanied by enhanced excision of cisplatin-induced interstrand crosslinks (13) . In particular, they demonstrated that the region around a cisplatin interstrand crosslink is susceptible to increased spontaneous decay, namely cytosine deamination, due to a local structural distortion in the duplex. This physical and chemical feature of the crosslinked DNA results in a uracil-specific BER response, which would occur near the interstrand crosslink and thus interfere with the normal repair processes in vivo. Consistently, the authors found that cells defective in uracil DNA glycosylase (UNG), APE1 or POLβ function, key elements of an effective BER reaction, exhibit a cisplatin-specific resistant phenotype.
Given the complex picture that is emerging regarding the role of BER in interstrand crosslink processing, we sought herein to better define the involvement of NEIL1 in the cellular response to trioxsalen (psoralen)-induced interstrand crosslinks.
EXPERIMENTAL PROCEDURES

Cells, reagents and statistical analysis
U2OS and HeLa cells were obtained from ATCC (Manassas, Virginia); mutant XPC15 and corrected XPC16 cell lines from Coriell Medical Institute (Camden, New Jersey); and NEIL1 knockdown and control LN428 cell lines from Trevigen (Gaithersburg, MD). Dulbecco's modified Eagle's media (DMEM) was acquired from Invitrogen Corporation (Carlsbad, CA). Vectorshield Hard Set mounting medium was obtained from Vector Laboratories (Burlingame, California), and trioxsalen, angelicin and Nacetylcysteine were from Sigma, Aldrich (St. Louis, MO). The chemical design and characterization of digoxigenin-tagged trimethylpsoralen (dig-pso) and digoxigenintagged dimethylangelicin (dig-ang) has been described previously (14) .
Plasmid construction and transfection
To generate the C-terminal fluorescentlytagged NEIL1 expression construct, the NEIL1 coding region was PCR amplified in 4% DMSO using the Hercules II Fusion Enzyme according to the manufacturer's guidelines (Stratagene, Agilent Technologies, Santa Clara, CA) with primers 5HNEIL1 (5'-CCCCAAGCTTGCCACCATGCCTGAGGGCCC CGAGCT-3') and 3ENEIL1 (5'-CGGAATTCCAGAGGCTGAGGTCCCCTCTG GT-3'), and a cDNA template obtained from Origene (Rockville, MD; catalog no. SC123674). The PCR product was digested accordingly and subcloned into the HindIII and EcoR1 restriction sites of either pmCherry-N1 or pAcGFP1-N1 (Clontech). Nucleotide substitutions were introduced into the WT pAcGFP-NEIL1 plasmid using the QuikChange II XL Site-Directed Mutagenesis Kit (Stratagene) to create the G83D, C136R and E181K variant GFP-fusion constructs.
HeLa, U2OS, XPC15 mutant or XPC16 complemented cells were grown in DMEM with 10% FBS, 1% penicillin/streptomycin, and 1% glutamate at 5% CO 2 and 37C. The designated plasmid was transfected into 200,000 cells, which had been adhered for 24 hr to a 35 mm glass bottom culture dish with a 10 mm microwell (MatTek Corporation, Ashland, MA), using the Dreamfect reagent according to the manufacturer's standard protocol (OZ Biosciences, Marseille, France). In brief, 1 µg of plasmid was combined with the Dreamfect reagent and incubated at room temperature for 20 min. After this time, the mixture was added to the adhered cells for 4 hr and then removed. Cells were incubated for 48 hr under standard culture conditions and used to determine the intracellular localization or recruitment dynamics of the specified fluorescently-tagged fusion protein. With the LN428 cell lines, an identical procedure (see above) was employed using a pEGFP-N3 vector that harbors full-length XPC (15) .
Protein intracellular location
HeLa or U2OS cells were transfected with the indicated plasmid using the approach outlined above in slide chambers. Forty-eight hr post transfection, the medium was removed and cells were sealed under a glass coverslip with 50 µl of Vectorshield Hard Set mounting medium with diamidino-2-phenylindole dye (DAPI). The slides were allowed to harden overnight at 4C, and were viewed using a Nikon Eclipse TE2000-E microscope equipped with a CCD camera (Hamamatsu, Tokyo, Japan) and various fluorescence modules. Velocity software (Improvision, PerkinElmer, Coventry, England) was used to capture and process images. All images were acquired using identical gain, exposure, sensitivity, and contrast settings.
Localized microirradiation was performed using the Nikon Eclipse TE2000-E microscope set-up described above, a SRS NL100 nitrogen pumped dye laser with Micropoint ablation system (Photonics Instruments, St. Charles, IL) adjusted via passage through a dye to generate a wavelength of 365 nm, and a CSU10 spinning disk system (Yokogawa, Japan). Laser power was attenuated in terms of percent intensity using Velocity software (see above). In particular, a defined laser intensity was directed to deliver pulses to a delineated rectangular region of interest (94 x 20 pixels, 0.16 µm/pixel) using a Plan Fluor x60/1.25 numerical aperture oil objective. Galvanometer-driven beam displacers oriented the laser beam, which fired randomly throughout the region until complete exposure was obtained; 300 nm was used for the diffraction limited spot size. The laser fires 3 ns pulses with a 10 Hz repetition rate with a power of 0.7 nanowatts, measured at the back aperture of the x60 objective at 365 nm. A setting of 1.7% (for psoralen) and 2.2% (for angelicin ) was used to create interstrand crosslinks or monoadducts in the targeted region. A setting of 2.7% was used to create free radical induced single strand breaks (16) . Thirty min prior to the experiment, cells (as indicated) were treated either with 5 µM psoralen (30 min at 37C), 40 µM angelicin (30 min at 37C), or not at all. Throughout the experiment, adhered cells were maintained at 80% humidity, 5% CO 2, and 37C using a live cell environmental chamber or CO 2 enhancement workhead (Slonet Scientific, Segensworth, United Kingdom). Live cells were subjected to site directed laser damage at various intensities (see above). The data was analyzed using the Velocity software listed above and "region of interest fluorescent intensity" was photographically recorded as specified. All images were acquired using identical gain, exposure, sensitivity, and contrast settings.
To examine the effects of the antioxidant N-acetylcysteine (NAC), repair proficient HeLa cells were transfected with the pAcGFP-NEIL1 plasmid (see above) and cultured for an additional 48 hr. NAC was then added to the media at a final concentration of 6 mM, and where indicated, psoralen was added 30 min prior to laser microirradiation. The cells were subsequently microirradiated at either 2.7% alone or 1.7% in the presence of psoralen. As described above, live cells were subjected to site directed laser damage and subsequent recruitment (or lack thereof) was photographically recorded. The data was analyzed and the images were acquired as detailed above.
Western blot analysis
Control and NEIL1 knockdown LN428 cell lines (Trevigen) were cultured in DMEM. Once cells reached 80% confluence, they were trypsinized, washed with PBS, and harvested by centrifugation. Cell pellets were frozen at -80 o C for one hr prior to extract preparation. Cells were re-suspended in 1 ml lysis buffer (50 mM Tris, pH 7.4, 1 mM EDTA, 1 mM DTT, 10% glycerol, 0.5 mM PMSF) and sonicated. Following centrifugation, a Bradford assay (BioRad, Hercules, CA) was run to determine the protein concentration of the supernatant (whole cell extract). Thirty µg of each extract was separated on a Nupage MOPS gel (Invitrogen), and the protein was transferred to a 0.2 µm PVDF membrane (Invitrogen) using standard blotting procedures. Anti-NEIL1 rabbit polyclonal antibody (Calbiochem, EMD Biosciences, San Diego, CA) was used as the primary antibody, followed by goat anti-rabbit HRP-conjugated secondary antibody (Pierce Biotechnology, Rockford, IL). Detection was carried out using a Pierce Super signal kit. β-Actin levels were determined on the same blot to ensure equal loading of whole cell extracts using a rabbit polyclonal antibody (Santa Cruz Biotechnology, Santa Cruz, CA) and the same goat anti-rabbit secondary as above. Blots were exposed to film and all data was analyzed using ImageQuant TL software (GE Healthcare).
Colony formation assays
Control and NEIL1 knockdown LN428 cell lines (Trevigen) were grown to confluence, trypsinized and counted, and one hundred cells were then transferred to each well of a six well plate. Treatments were carried out at the designated concentrations of trioxsalen (plus UVA light using a UVA Rayonet box from Southern New England Ultraviolet Company (Branford, CT)) as outlined previously (16) . Cells were then gently washed twice with 1X PBS, and incubated for 10 days with fresh DMEM to allow individual colonies to form. Colonies were stained with methylene blue and counted, and the percent survival determined relative to the untreated control.
Psoralen repair kinetics
Control and NEIL1 knockdown cells (Trevigen) were seeded (2x10 5 ) in a 35 mm glass bottom culture dish for 24 hr. These cells were treated with 20 μM dig-pso and incubated at 37C for 30 min prior to laser treatment at 1.7% intensity (14, 16) . After the laser treatment, cells were fixed either immediately or at the indicated time point in 4% formaldehyde for 10 min at room temperature. Fixed cells were permeabilized with 0.5% Triton X-100, 1% BSA, 100 mM Glycine and 0.2 mg/mL EDTA in PBS on ice for 10 min, and subsequently digested with RNAse A. Cells were blocked with 10% goat serum in PBS with 0.01% sodium azide for 1 hr at 37C. Immunofluorescence staining using a primary digoxigenin antibody (Abcam, Cambridge, MA) and γH2AX antibody (Santa Cruz) was carried out. Secondary antibodies (Alexa Fluor goat antimouse and Alexa Fluor goat anti-rabbit (Molecular Probes)) were used for visualization. Approximately 20-25 cells were visualized for each time point. Mean Intensity of dig-pso from each cell at the damage site was measured (Velocity 6.01 version, Perkin Elmer) and corrected for background with background intensity from undamaged site of that respective cell.
Incision and binding assays
The oligonucleotides used to create the different DNA substrates were synthesized and gel purified by Integrated DNA Technologies, Inc. (San Jose, CA): 34-5OHC, CTGCAGCTGATGCGC[5OHC]GTACGGATCC CCGGGTAC; 34G, GTACCCGGGGATCCGTACGGCGCATCAGC TGCAG; D21, CCGCGGCGTACCGGCCGCGGC; and C21, TTGCCGCGGCCGGTACGCCGC GG. To generate the interstrand crosslink-containing duplex (D21/C21 ICL), 5 nmol of each D21 and C21 were annealed in TE buffer, and this 5 µM DNA solution was then incubated with 50 µM 4, 5', 8-trimethylpsoralen for 1 hr in the dark in 5 mM Tris (pH 7.6), 50 mM NaCl and 0.2 mM EDTA. This mixture was subsequently irradiated for 20 min with UVA light (365 nm) on ice. The irradiated samples were purified over a DIONEX DNAPac ion exchange column on a Shimadzu HPLC system (LC-10ADvp) with a dual wavelength detector (SPD-10ADvp) and an auto injector (SIL-10AVvp). A solution of 25 mM NaOH (mobile phase A) and 1 M NaCl in 25 mM NaOH (mobile phase B) was used for separation of uncrosslinked and crosslinked DNA. A gradient of 2 min 10-50% B, 20 min 50-90% B, and 21 min 90-100% B was employed with a flow rate of 1.0 mL/min. The fractions were immediately neutralized after collection by the addition of Tris buffer, pH 7.4. The fractions containing the interstrand crosslinked DNA were pooled and desalted by dialysis in water in a 2,000 molecular weight cutoff cassette (Thermo Scientific, Rockford, IL) at 4⁰C overnight and concentrated in a Speed-vac concentrator. The D21/C21 ICL substrate was 5' end-labeled by T4 polynucleotide kinase (New England Biolabs, Beverly, MA) and [γ-32 P] ATP (3000 Ci/mmol, Perkin Elmer, Waltham, MA) using a standard protocol. For the 5-hydroxycytosine (5OHC) positive control substrate, the damage-containing strand was 5' end-labeled prior to annealing to the cold complementary 34G strand. For the D21/C21 duplex that did not contain the site-specific interstrand crosslink, the C21 strand was radiolabeled prior to annealing to the complementary D21 oligonucleotide.
To monitor NEIL1 glycosylase and AP lyase activities, human NEIL1 protein (New England Biolabs, Ipswich, MA) was added to a reaction mixture at the indicated amounts with 1 pmol of the appropriate oligonucleotide substrate in 10 µl of 1X endonuclease VIII buffer (New England Biolabs). After incubation at 37C for 10 min, the reaction was stopped by the addition of formamide loading buffer (95% formamide, 10 mM EDTA, bromophenol blue and xylene cyanol) and heated to 90C for 10 min followed by incubation on ice for 3 min. The reactions were then resolved on a 20% polyacrylamide denaturing urea gel (National Diagnostics, Atlanta, GA) at 250 mV for 2.5 hr. The gel was exposed to a phosphor screen (GE Healthcare, Pittsburgh, PA), which was subsequently imaged on a GE Healthcare Typhoon Trio+ Variable Mode Imager. To assess stable DNA binding, electrophoretic mobility shift assays (EMSAs) were performed by incubating NEIL1 protein (New England Biolabs) at 7.5, 22.5 or 75 ng with 100 fmol of the appropriate labeled substrate in a 10 µl volume of 70 mM MOPS, pH 7.5, 1 mM EDTA, 1 mM DTT and 5% glycerol. Following incubation for 15 min on ice, binding reactions were resolved on an 8% polyacrylamide non-denaturing gel in TBE at 100 V for 120 min. The gel was exposed and imaged as above, and all data was analyzed using ImageQuant software (GE Healthcare).
RESULTS
Recruitment of NEIL1 to site-specific DNA damage
As a means of evaluating the role of DNA repair proteins in an interstrand crosslink response, we have employed a strategy whereby we transiently express fluorescently-tagged fusion proteins in human cells and monitor their recruitment dynamics to and retention time at specified sites of laser-induced DNA damage. In these experiments, photoactivated trioxsalen (psoralen) is used as the interstrand crosslinking agent, and angelicin is used as a control to generate monoadducts exclusively ((16); further details below). Our studies herein focus on the NEIL1 DNA glycosylase, since this protein has been previously shown to play multiple roles in interstrand crosslink repair (10, 12) . When transiently expressed in human cervical carcinoma (HeLa) cells, NEIL1 tagged with GFP at the Cterminus exhibits diffuse nuclear localization, with a significant concentration in the nucleolus ( Figure  1A ). NEIL1 tagged with an alternative fluorescent protein (mCherry) displays a similar pattern of intracellular localization whether expressed in HeLa cells (data not shown) or human osteosarcoma U2OS cells ( Figure 1B ).
After confirming predominantly nuclear targeting of the tagged NEIL1 protein, we determined the recruitment dynamics of GFP-NEIL1 to defined sites of DNA damage using laser microirradiation coupled with confocal microscopy. Initially, we employed a high laser dose (2.7%) known to generate DNA damage (likely oxidative lesions; see below) processed by the BER pathway to test the functionality of the GFP-NEIL1 fusion protein. As shown in Figure 2 (top row), nucleoplasmic, and not apparently nucleolar, GFP-NEIL1 rapidly accumulates at the site of high dose irradiation. To determine whether NEIL1 responds to psoralen-induced adducts, pGFP-NEIL1 transfected HeLa cells were incubated with trioxsalen in culture, and then specified regions within the nucleus were targeted with laser intensities sufficient to activate the compound, but too low to produce significant oxidative lesions (1.7%). As seen in Figure 2 (second row), GFP-NEIL1 was immediately recruited to sites of DNA interstrand crosslink damage (i.e., at the 5 sec time point), dispersed completely by 8 min, and didn't re-localize to the irradiated region out to 60 min post-laser treatment (not shown). Importantly, the fusion protein did not recruit to sites treated with the low (1.7%) laser dose alone (i.e., no psoralen; Figure 2 , middle row).
To determine whether the GFP-NEIL1 response observed above is specific to psoraleninduced interstrand crosslinks and not monoadducts, we employed angelicin, a photoreactive analogue of psoralen that can form only monoadducts repaired by nucleotide excision repair (NER). As depicted in Figure 2 , GFP-NEIL1 responds neither to angelicin + laser (fourth row) nor to the corresponding laser alone control (2.2%, bottom row), suggesting that the glycosylase is recognizing some feature specific to a trioxsalen-induced interstrand crosslink. Immunofluorescence staining with antibody against XPB confirmed that under our treatment/exposure conditions involving angelicin + laser, we were indeed generating site-specific DNA monoadducts that prompt a classic NER response (data not shown).
Role of oxidative damage and XPC in the NEIL1 response
To determine the contribution of oxidative damage to the NEIL1 response reported above, we employed the anti-oxidant NAC. NAC is the Nacetyl derivative of the amino acid L-cysteine, and its thiol (sulfhydryl) group confers anti-oxidant effects through reduction of free radicals. We postulated that NAC treatment would abrogate any response that is reliant on the formation of oxidative DNA damage. As seen in Figure 3A , NAC completely suppressed NEIL1 recruitment to sites of the high laser dose treatment (top row), but had no effect on the response to psoralen + low laser (bottom row). These results are consistent with our conclusions that the high laser dose elicits a general BER response and that the NEIL1 protein is reacting to something specific to the crosslinking agent.
Prior studies have shown that the NER damage recognition factor, XPC, which exists as part of a complex with HR23B, is an early arriver to DNA interstrand crosslink damage and directs a conventional repair response (16) . To determine whether XPC facilitates the observed NEIL1 accumulation, we examined GFP-NEIL1 recruitment dynamics in cells deficient in XPC. As seen in Figure 3B , GFP-NEIL1 responds similarly to psoralen + laser independent of the presence of XPC, suggesting that the glycosylase is not being recruited via the NER complex.
Silencing of NEIL1 improves trioxsalen crosslink resistance and removal
The results of the above experiments indicate an involvement of NEIL1 in a trioxsaleninduced interstrand crosslink response. To evaluate whether NEIL1 might influence the repair of DNA interstrand crosslinks, we determined the sensitivity of control and NEIL1 shRNA lentivirus transduced LN428 glioblastoma cells to psoralen + UVA exposure. Reported quantification (Trevigen) indicates that there is an ~92% knockdown of the NEIL1 transcript in the NEIL1 shRNA stably transduced cells as determined by RT-PCR. We performed western blot analysis of control and NEIL1 knockdown cell extracts and found an ~72% (SE=2.3%) reduction in NEIL1 protein ( Figure 4A) . Notably, NEIL knockdown cells displayed an increased resistance to psoralen + UVA relative to the control cells as determined by colony formation assays ( Figure 4B ), implying a negative impact of the DNA glycosylase on the resolution of cytotoxic DNA interstrand crosslink damage.
To examine whether NEIL1 directly affects the repair of DNA interstrand crosslinks, we monitored the removal kinetics of psoralen damage in the control and NEIL1 knockdown LN428 cell lines. In particular, the excision of psoralen adducts was followed by using a digoxigenin-labeled psoralen compound (dig-pso) as previously described (14) . As shown in Figure  4C , after site-specific UVA irradiation, disappearance of the labeled dig-pso compound was less efficient in the control cells in comparison with the NEIL1 knockdown cells, consistent with the idea that the glycosylase interferes with interstrand crosslink removal.
NEIL1 binds psoralen interstrand crosslinkcontaining DNA substrates
Given the improved excision kinetics of psoralen-induced interstrand crosslinks and the increased psoralen + UVA resistance of NEIL1 knockdown cells, and in light of the published work by Patrick and colleagues suggesting an interfering role of BER in the cisplatin interstrand crosslink response (13), we determined whether NEIL1 displayed binding or enzymatic activity on a synthetic psoralen interstrand crosslink DNA substrate. In the initial experiments, NEIL1 was found to exhibit no noticeable glycosylase or AP lyase (strand incision) activity on psoralen interstrand crosslink-containing duplex DNA (D21/C21 ICL), while displaying significant repair activity on control 5OHC-containing double stranded substrates (Supplementary Figure 1) . However, as shown in Figure 5 , we did observed stable complex formation in EMSAs of NEIL1 with the psoralen crosslinked oligonucleotide duplex, D21/C21 ICL DNA. This binding activity was not as pronounced as the positive control 5OHC substrate, but was at least 4-fold better than the non-damaged D21/C21 duplex (p = 0.007).
XPC recruitment is enhanced in NEIL1-deficient cells
The observation that NEIL1 binds stably to the D21/C21 ICL DNA substrate suggests a molecular mechanism for how the protein might interfere with the efficient removal of psoralen interstrand crosslinks in vivo ( Figure 4C ). To explore this concept further, we determined the recruitment kinetics of a C-terminal GFP-tagged XPC to trioxsalen-induced DNA interstrand crosslinks in the control and NEIL1 knockdown LN428 cells. We reasoned that if NEIL1 binding interfered with normal damage recognition and processing, then NEIL1-deficient cells should see a more rapid accumulation of XPC at the site of the interstrand crosslink. Indeed, as seen in Figure  6 , we observed that XPC recruitment to trioxsalen crosslinks reached maximal signal intensity within the first two minutes in the NEIL1 knockdown cells, whereas maximal signal intensity was not achieved in the control cells until at least five minutes post laser irradiation. These data support the conclusion that the intracellular concentration of NEIL1 can affect substrate recognition by the XPC protein.
Response of NEIL1 variants to oxidative DNA damage and psoralen-induced interstrand crosslinks
NEIL1 amino acid substitution variants have been identified in the normal population and in patients with primary sclerosing cholangitis and/or cholangiocarcinoma, and some of these (e.g., G83D, C136R and E181K) have been shown to exhibit impaired DNA repair activity and/or protein integrity (17, 18) . In particular, the G83D variant (rs5745906; <1% frequency) was devoid of glycosylase nicking activity for most oxidative base lesions, and displayed only β-elimination AP lyase activity for pre-generated abasic sites, as opposed to the β,δ-activity seen for the wild-type enzyme (17, 18) . The C136R variant (rs5745907; <1% frequency) exhibited substantially reduced DNA glycosylase activity for oxidative base damage, and displayed inefficient and uncoupled AP lyase activity (17) . The NEIL1 E181K variant (observed in 1 of 29 patients with primary sclerosing cholangitis) formed inclusion bodies when expressed in bacteria and was unable to be purified and characterized biochemically (18) . We examined the intracellular distribution and recruitment dynamics to sites of high laser dose alone or to psoralen + laser of these three NEIL1 variants, as they represent possible rare alteredfunction susceptibility or disease-related mutants.
As shown in Figure 7 , the G83D and E181K GFP-tagged fusion proteins exhibit a similar intracellular distribution pattern as seen for WT NEIL1, i.e., diffuse nuclear staining with a high degree of nucleolar localization, whereas the C136R variant displays a more disperse nuclear staining pattern, and in some instances, formed noticeable spontaneous aggregates and/or had significant cytoplasmic presence (Supplementary Figure 2) ; a normal pattern of distribution for G83D and E181K had been reported previously (18) . Recruitment studies at the high laser dose found that E181K exhibits a shorter retention time (6 min relative to 8 min for WT), that G83D displays a dramatically reduced signal intensity as well as a shorter retention time (2 min), and that C136R does not respond at all (Figure 7A and C) . In experiments involving psoralen + laser ( Figure  7B and D) , E181K again showed a slightly shorter retention time (6 min relative to 8 min for WT), whereas G83D displayed an increased signal intensity as well as a longer retention time (12 min), and C136R exhibited a longer retention time (12 min), all relative to WT NEIL1. These data are consistent with prior studies indicating an impaired function for these variants (17, 18) and suggest that the two DNA damage responses (i.e., to oxidative lesions at high laser dose or interstrand crosslinks at trioxsalen + laser) involve different mechanisms of protein recruitment and retention.
DISCUSSION
In our studies here, we found NEIL1 to be a rapid responder to psoralen-induced interstrand crosslinks, belonging to a group of proteins, which have been deemed immediate early damage responders or sensors (6, 19) . This seemingly instantaneous response (seen at 5 sec postirradiation for NEIL1), previously termed stage I of the repair cascade (5), likely attracts proteins that are reacting directly to a DNA modification (e.g. a base lesion or strand break) -either independently or as part of a complex -and not to DNA processing intermediates or posttranslational modifications that arise after the initial substrate recognition. XPC, a NER factor known to participate in G1 phase interstrand crosslink detection and repair, accumulates at sites of psoralen-induced DNA damage essentially immediately (16), like NEIL1. However, XPC persists at these laser-induced interstrand crosslink foci for up to an hour, whereas NEIL1 disappears by 8 min. The difference in their persistence profiles and the fact that NEIL1 accumulates in the by guest on October 5, 2017 http://www.jbc.org/ Downloaded from absence of XPC would seem to indicate that the glycosylase is not directly involved in the repair of the interstrand crosslink, but instead is attracted to a unique feature of the crosslinked DNA.
Our observation that NEIL1 binds with higher affinity to psoralen interstrand crosslinkcontaining duplex DNA (D21/C21 ICL) than undamaged DNA (D21/C21) indicates some specificity of the protein for crosslink damage. While at present it is unclear what attribute of the interstrand crosslink duplex NEIL1 is recognizing, the glycosylase has been shown to exhibit increased activity on base lesions within DNA bubble structures (20) . Notably, prior work has found that psoralen interstrand crosslinks can promote a local DNA structural change, with potential helix unwinding (21), possibly creating a binding site for stable NEIL1 complex formation, such as an undamaged flipped-out base. It is also feasible that such structural distortions could make the region around the interstrand crosslink prone to oxidation in vivo, resulting in an even more favorable substrate for NEIL1 binding. Although our biochemical assays have not revealed NEIL1 incision activity on psoralen interstrand crosslink substrates, an observation that appears consistent with prior experimental work (10), enzymatic processing by the glycosylase at or near the interstrand crosslink site in vivo cannot be excluded. Thus, whether the NEIL1 protein response is part of a more general BER process intracellularly is unknown.
NEIL1 exhibits a nearly identical kinetic profile in response to both oxidative DNA damage (high laser dose) and psoralen interstrand crosslinks (trioxsalen + laser). However, these responses are clearly distinct, as NEIL1 recruitment to only the high laser dose was abrogated by treatment with the anti-oxidant NAC. This finding supports the notion that the glycosylase is recognizing something unique about the crosslinked duplex, and not simply oxidative base modifications in DNA. Moreover, it is noteworthy that the two NEIL1 protein variants known to have substantially reduced DNA glycosylase activity, G83D and C136R (17, 18) , have little or no response to the high laser exposure, yet retain a near normal, even more intense response to trioxsalen + laser. This observation is consistent with (i) the high laser dose creating substrate lesions for BER enzymes (i.e., oxidative DNA damage) and (ii) the two responses involving a distinct NEIL1 recognition mechanism that can be uncoupled via specific mutations. Moreover, our results support the notion that these two rare reduced-function population variants, G83D and C136R, may influence disease risk, particularly for clinical conditions that involve oxidative stress and associated base lesions. The fact that we observed a near normal response for the disease-associated E181K variant may imply that this protein exhibits essentially WT repair activities, a feature that was not assessable biochemically due to the formation of inclusion bodies when expressed in bacteria (18) . We note that neither the oxidative damage nor the interstrand crosslink response appears to involve DNA replication, since all cells analyzed within the unsynchronized population displayed similar NEIL1 response kinetics.
Our observations that NEIL1 deficiency leads to a more rapid excision of psoralen-induced DNA damage and increased resistance to psoralen + UVA is seemingly inconsistent with prior studies suggesting a role for NEIL1 and BER in psoralen monoadduct or crosslink remnant excision (10, 12) . While the exact reason for this apparent discrepancy is unknown, it could reflect differences in the cellular background and/or the use of 8-methoxypsoralen in the earlier work, as this agent, unlike trioxsalen (which was employed herein) generates an obligate 20% monoadducts; trioxsalen, conversely, produces crosslinks at a 56:1 ratio in comparison to monoadducts (<2%) ( (11) and unpublished observation). Although we did not observe recruitment to angelicin, our studies cannot completely exclude the possibility that NEIL1 has a role in psoralen monoadduct repair, as this was not explicitly addressed. However, since we did not see a stage II response for NEIL1 to psoralen-induced DNA damage, which should occur around 10 min post-irradiation as defined by recruitment of XPE to sites of psoralen interstrand crosslinks (16), our studies do not support a role for the glycosylase in remnant processing in vivo. It seems likely that proteins such as the damage-specific DNA binding factor, DDB1, a key marker for the second stage of the repair process (16) , would outcompete NEIL1 in cells. We emphasize that none of our experiments rule out the possibility that NEIL1 excises psoralen monoadducts or interstrand crosslink remnants from three-stranded DNA structures in vitro.
In total, our results suggest a model whereby NEIL1 arrives early at the site of the psoralen interstrand crosslink, forms a stable complex at this location, and interferes with the main processes of crosslink resolution (i.e., NER and recombinational repair, including XPC recruitment), leading to slower crosslink removal and increased sensitivity to trioxsalen + UVA. This model is broadly consistent with the model of Patrick and colleagues, who based on a series of biochemical and cell biology experiments proposed that, upon cytosine deamination near a cisplatin interstrand crosslink, a uracil-directed BER response will hamper the normal cellular repair processes for the crosslink damage (13) . Our studies indicate an interfering role for the NEIL1 glycosylase in the repair of psoraleninduced DNA interstrand crosslinks that involves binding at the crosslink site, seemingly without the formation of a cognate substrate. Future work will need to determine whether the NEIL1 response described herein is unique to psoralen crosslinks or whether other crosslinking agents can generate comparable binding sites for stable NEIL1 complex formation.
It is interesting to note that historically most studies aimed at identifying pathways involved in crosslinking agent resistance have selected for clones that are resistant to the damaging compound and then searched for upregulated genes. As such, genes that when downregulated play an important role in resistance would have been missed. In light of the results herein and of Patrick and colleagues (13) , it seems reasonable to predict that downregulation of specific DNA glycosylases will give rise to crosslinking agent resistance. Thus, it would seem to be worthwhile to return to earlier experiments and ask whether any of the resistant clones show significant reductions in DNA glycosylase gene expression. Moreover, in addition to providing a potential means of resistance to crosslinking agents, decreased expression of a repair glycosylase could provide a selective advantage for cell survival in the form of a mutator phenotype. Specifically, reduced DNA glycosylase activity would result in base damage accumulation and the potential for mutagenic replicative events, some of which could aid in rapid adaptation and the development of therapeutic agent resistance. Going forward, it seems reasonable that besides defining the repair capacity of the canonical interstrand crosslink responses, namely the NER factors XPF/ERCC1 and homologous recombination (22) , the levels of DNA glycosylases should be considered when predicting patient responsiveness to crosslinking drugs used in the clinic. Significantly, NEIL1 protein levels and activity have been shown to be altered (primarily decreased) in cancer cells, due to both genetic and epigenetic factors (23, 24) . Psoralen sensitivity. NEIL1 KD and Cntl cells were treated with the indicated doses of trioxsalen + UVA, plated, and cultured to allow for colony formation. Percent survival is plotted relative to the untreated samples, and shown is the average and standard deviation of at least 8 data points from 3 independent experimental runs. *, p < 0.05; **, p < 0.0003. (C) Dig-pso damage removal kinetics. LN428 KD and Cntl cells were incubated with dig-pso, and following 1.7% intensity laser treatment, the digoxigenin signal was detected and quantified at the indicated time points (left, images). The normalized dig-pso intensity was plotted against time, with the values shown representing the average and standard deviation of three independent experimental measurements (right, graph). *, p < 0.007. H2AX designates the region of interest to which the laser was directed. Reported p values were derived from ANOVA Single Factor comparative analysis of the data sets at the specified psoralen concentration or time point. 
